Hinge Health beats Q4 revenue estimates

Hinge Health

10/02/2026 21:15

Overview

Digital musculoskeletal care firm's Q4 revenue rose 46% yr/yr, beating analyst expectations

Non-GAAP income from operations for Q4 increased 124% yr/yr

Company repurchased $65 mln of Class A common stock in Q4

Outlook

Hinge Health expects Q1 2026 revenue between $171 mln and $173 mln

Company forecasts full-year 2026 revenue between $732 mln and $742 mln

Hinge Health anticipates Q1 2026 non-GAAP operating margin of 18%

Result Drivers

COMMERCIAL MOMENTUM - CEO Daniel Perez attributed strong Q4 performance to high win rates and a successful selling season

EXPANDING MARGINS - Co reported increased gross margins, contributing to improved financial results

INCREASED ELIGIBLE LIVES - Number of contracted lives rose to 25 million, supporting revenue growth

Key Details

Metric
Beat/Miss
Actual
Consensus Estimate
Q4 Revenue
Beat
$170.73 mln
$156.64 mln (16 Analysts)
Q4 Net Income
$32.10 mln
Q4 Gross Profit
$144.03 mln
Q4 Income from Operations
$27.26 mln
Q4 Pretax Profit
$32.22 mln


Analyst Coverage

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 16 "strong buy" or "buy", 1 "hold" and no "sell" or "strong sell"

The average consensus recommendation for the software peer group is "buy"

Wall Street's median 12-month price target for Hinge Health Inc is $63.50, about 97.5% above its February 9 closing price of $32.16

Press Release: ID:nBwb0Rcs2a

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)